AURORA, Colorado, Sept. 14 [Category: Medical] -- The International Association for the Study of Lung Cancer posted the following news release:

* * *

Investigational Immunotherapy Nearly Doubles Overall Survival Compared with Docetaxel in Advanced Squamous NSCLC

*

(SEOUL, Republic of Korea -Tuesday, September 15th, 9:45 a.m. Korea Standard Time) -Patients with metastatic squamous non-small cell lung cancer (NSCLC) whose disease progressed follo . . .

Click here for more information about our products